I've think I've (now) read everything CHM have published re the NK platform and I'm still not sure how much they've paid for it nor what their obligations are re development costs?
Aside from the $30m equity placement agreement that was announced after the exclusive option agreement was exercised.
These treatments won't bring an end to chemotherapies if they can't demonstrate superior efficacy.
CHM Price at posting:
1.4¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)